Abediterol

Abediterol
Names

IUPAC name (R)-5-(2-((6-(2,2-difluoro-2-phenylethoxy)hexyl)amino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
Identifiers
CAS Registry Number	915133-65-2^Y
ChEMBL	ChEMBL3039530
ChemSpider	10136846
InChI InChI=1S/C25H30F2N2O4/c26-25(27,18-8-4-3-5-9-18)17-33-15-7-2-1-6-14-28-16-22(31)19-10-12-21(30)24-20(19)11-13-23(32)29-24/h3-5,8-13,22,28,30-31H,1-2,6-7,14-17H2,(H,29,32)/t22-/m0/s1 Key: SFYAXIFVXBKRPK-QFIPXVFZSA-N InChI=1/C25H30F2N2O4/c26-25(27,18-8-4-3-5-9-18)17-33-15-7-2-1-6-14-28-16-22(31)19-10-12-21(30)24-20(19)11-13-23(32)29-24/h3-5,8-13,22,28,30-31H,1-2,6-7,14-17H2,(H,29,32)/t22-/m0/s1 Key: SFYAXIFVXBKRPK-QFIPXVFZBE
Jmol-3D images	Image
KEGG	D10219
PubChem	11962616
SMILES FC(F)(c1ccccc1)COCCCCCCNC[C@H](O)c3ccc(O)c2c3\C=C/C(=O)N2
UNII	QXA167CM6F
Properties
Molecular formula	C₂₅H₃₀F₂N₂O₄
Molar mass	460.51 g·mol⁻¹
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
Infobox references

Abediterol (INN^[1]) is an experimental drug candidate for the treatment of asthma and chronic obstructive pulmonary disease. It is currently under development by the Spanish pharmaceutical company Almirall and is in Phase II clinical trials.^[2] It acts as a β₂-adrenergic agonist.^[3]^[4]

References